Europe and Northern America vs South Korea: Percentage of bloodstream infection due … methicillin-resistant
Europe and Northern America
8.0%
in 2022
South Korea
45.7%
in 2022
Europe and Northern America rank
14th
South Korea rank
13th
Percentage of bloodstream infection due … methicillin-resistant over time
- Europe and Northern America
- South Korea
How they compare
South Korea currently reports 45.7% against 8.0% in Europe and Northern America, a difference of 37.7%.
That makes South Korea's figure about 5.7 times Europe and Northern America's.
Across all 6 years both countries report, South Korea has been ahead every year.
Europe and Northern America ranks 14th and South Korea ranks 13th of 15 groups.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe and Northern America | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 14.2% | 49.7% | 35.5% | South Korea |
| 2020s | 8.5% | 46.2% | 37.6% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Europe and Northern America or South Korea?
- South Korea, at 45.7% against 8.0% in Europe and Northern America as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Europe and Northern America and South Korea?
- 37.7%, with South Korea ahead.
- How many years of comparable data are there for Europe and Northern America and South Korea?
- 6 years are reported by both, from 2017 to 2022.
- How do Europe and Northern America and South Korea rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Europe and Northern America ranks 14th and South Korea ranks 13th of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.